In addition, we have found that rs4789936 polymorphism is associated with an advanced stage, lymph node metastases, and a PR positive status, indicating that the rs4789936 polymorphism may affect the prognosis of breast cancer patients. This evidence concerns the gene PGR and metastatic malignant neoplasm in the lymph nodes.